Verve Therapeutics
VERV
#6795
Rank
A$0.77 B
Marketcap
$9.18
Share price
11.24%
Change (1 day)
-56.30%
Change (1 year)

Verve Therapeutics (VERV) - Cash on Hand

Cash on Hand as of September 2024 : A$0.86 Billion

According to Verve Therapeutics's latest financial reports the company has A$0.86 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Verve Therapeutics - Cash on Hand chart (from 2020 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31A$0.91 B12.33%
2022-12-31A$0.81 B63.98%
2021-12-31A$0.49 B430.14%
2020-12-31A$93.78 M249.59%
2019-12-31A$26.82 M